Integrated phytochemical profiling and molecular modelling of Magnolia officinalis bark-derived bioactive compounds interacting with apoptosis-associated proteins relevant to cisplatin-induced cellular injury
Frontiers in Bioinformatics · 05.11.2026 · 6
DOI: 10.3389/fbinf.2026.1952073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioinformatics, online erschienen am 05.11.2026. Verfasst von Naveen Vijiyakumar und 1 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Cisplatin is an effective chemotherapeutic agent; however, oxidative stress and apoptosis-associated signalling contribute to both its therapeutic effects and dose-limiting toxicities. This study investigated the phytochemical composition and antioxidant properties of Magnolia officinalis bark extract and explored the predicted interactions of selected constituents with the apoptosis-associated proteins caspase-3 and BCL-2.
Methods
Phenolic and flavonoid contents, DPPH and ABTS radical-scavenging activities, chromatographic–mass spectrometric profiling, molecular docking, pharmacokinetic and toxicity predictions, 100-ns molecular dynamics simulations, and MM/GBSA calculations were employed.
Results
Among the solvent extracts evaluated, the methanolic extract exhibited the highest phenolic (64.55 ± 0.65 mg GAE/g dry extract) and flavonoid (21.90 ± 0.55 mg QE/g dry extract) contents. It also demonstrated concentration-dependent DPPH and ABTS radical-scavenging activities, with IC₅₀ values of 143.02 and 326.01 µg/mL, respectively. Phytochemical profiling provided tentative evidence for multiple constituents, with magnolol and honokiol prioritised for computational evaluation. Molecular docking and dynamics analyses indicated predicted protein–ligand interactions and complex-specific conformational behaviour, including substantial magnolol displacement or rearrangement in the caspase-3 system during approximately 45–65 ns.
Discussion
The findings provide insights into the antioxidant and phytochemical properties of Magnolia officinalis bark extract and identify candidate constituents for further investigation. However, the computational results are hypothesis-generating and do not establish functional modulation of caspase-3 or BCL-2. Because cisplatin exposure and target-specific activity were not experimentally evaluated, conclusions regarding cytoprotection, chemosensitisation, or target activation/inhibition cannot be drawn. Further validation using target-specific biochemical assays and cisplatin-exposed cellular models is warranted.
Zitieren
APA
Vijiyakumar, N., & Prince, S. E. (2026). Integrated phytochemical profiling and molecular modelling of Magnolia officinalis bark-derived bioactive compounds interacting with apoptosis-associated proteins relevant to cisplatin-induced cellular injury. Frontiers in Bioinformatics, 6. https://doi.org/10.3389/fbinf.2026.1952073
Vancouver
Vijiyakumar N, Prince SE. Integrated phytochemical profiling and molecular modelling of Magnolia officinalis bark-derived bioactive compounds interacting with apoptosis-associated proteins relevant to cisplatin-induced cellular injury. Frontiers in Bioinformatics. 2026;6. doi:10.3389/fbinf.2026.1952073
BibTeX
@article{Vijiyakumar2026,
author = {Vijiyakumar, Naveen and Prince, Sabina Evan},
title = {Integrated phytochemical profiling and molecular modelling of Magnolia officinalis bark-derived bioactive compounds interacting with apoptosis-associated proteins relevant to cisplatin-induced cellular injury},
journal = {Frontiers in Bioinformatics},
year = {2026},
volume = {6},
doi = {10.3389/fbinf.2026.1952073}
}
EUVIMED